DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Richeldi L. et al.
Effect of dose reductions, treatment interruptions and dose intensity on decline in lung function with nintedanib in patients with idiopathic pulmonary fibrosis (IPF): results from the INPULSIS® trials.
PFF Summit; 2015
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.